<SEC-DOCUMENT>0001564590-21-056180.txt : 20211110
<SEC-HEADER>0001564590-21-056180.hdr.sgml : 20211110
<ACCEPTANCE-DATETIME>20211110160739
ACCESSION NUMBER:		0001564590-21-056180
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20211110
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211110
DATE AS OF CHANGE:		20211110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Trevi Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001563880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				450834299
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38886
		FILM NUMBER:		211396589

	BUSINESS ADDRESS:	
		STREET 1:		195 CHURCH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510
		BUSINESS PHONE:		203-304-2499

	MAIL ADDRESS:	
		STREET 1:		195 CHURCH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>trvi-8k_20211110.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-11-10T19:26:28.2343383+00:00 -->
<!-- Version            : 5.0.1.702 -->
<!-- Package ID         : 818557e885c3469b91c33895db5b4c14 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:trvi="http://www.trevitherapeutics.com/20211110" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
trvi-8k_20211110.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000000" name="dei:AmendmentFlag" contextRef="C_0001563880_20211110_20211110">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000001" name="dei:EntityCentralIndexKey" contextRef="C_0001563880_20211110_20211110">0001563880</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="trvi-20211110.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001563880_20211110_20211110">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001563880</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-11-10</xbrli:startDate>
					<xbrli:endDate>2021-11-10</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, D.C. 20549 </p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000002" name="dei:DocumentType" contextRef="C_0001563880_20211110_20211110">8-K</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) of </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">the Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of report (Date of earliest event reported): <ix:nonNumeric id="F_000003" name="dei:DocumentPeriodEndDate" contextRef="C_0001563880_20211110_20211110" format="ixt:datemonthdayyearen">November 10, 2021</ix:nonNumeric> </p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000004" name="dei:EntityRegistrantName" contextRef="C_0001563880_20211110_20211110">Trevi Therapeutics,&#160;Inc.</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact Name of Registrant as Specified in Charter) </p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001563880_20211110_20211110" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0001563880_20211110_20211110">001-38886</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001563880_20211110_20211110">45-0834299</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Incorporation)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS&#160;Employer</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification&#160;No.)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityAddressAddressLine1" contextRef="C_0001563880_20211110_20211110">195 Church Street</ix:nonNumeric>, <ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine2" contextRef="C_0001563880_20211110_20211110">14<span style="font-size:8.5pt;">th</span> Floor</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000010" name="dei:EntityAddressCityOrTown" contextRef="C_0001563880_20211110_20211110">New Haven</ix:nonNumeric>, <ix:nonNumeric id="F_000011" name="dei:EntityAddressStateOrProvince" contextRef="C_0001563880_20211110_20211110" format="ixt-sec:stateprovnameen">Connecticut</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000012" name="dei:EntityAddressPostalZipCode" contextRef="C_0001563880_20211110_20211110">06510</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Offices)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric id="F_000013" name="dei:CityAreaCode" contextRef="C_0001563880_20211110_20211110">(203)</ix:nonNumeric> <ix:nonNumeric id="F_000014" name="dei:LocalPhoneNumber" contextRef="C_0001563880_20211110_20211110">304-2499</ix:nonNumeric></p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Not applicable </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former Name or Former Address, if Changed Since Last Report) </p>
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="font-style:italic;">see</span> General Instruction A.2. below): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000015" name="dei:WrittenCommunications" contextRef="C_0001563880_20211110_20211110" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:SolicitingMaterial" contextRef="C_0001563880_20211110_20211110" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:PreCommencementTenderOffer" contextRef="C_0001563880_20211110_20211110" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001563880_20211110_20211110" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%; border-bottom:solid 1pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1%; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">symbol(s)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1%; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">on which registered</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:Security12bTitle" contextRef="C_0001563880_20211110_20211110">Common stock, $0.001 par value per share</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:TradingSymbol" contextRef="C_0001563880_20211110_20211110">TRVI</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:39%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:SecurityExchangeName" contextRef="C_0001563880_20211110_20211110" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </p>
<p style="text-align:right;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000022" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001563880_20211110_20211110" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span> </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000023" name="dei:EntityExTransitionPeriod" contextRef="C_0001563880_20211110_20211110" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span> </p>
<p style="border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.02 Results of Operations and Financial Condition </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 10, 2021, Trevi Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;) announced its financial results for the quarter ended September 30, 2021. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information provided under Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.01. Financial Statements and Exhibits. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Exhibits </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:8.36%; border-bottom:solid 1pt transparent;white-space:nowrap;">
<p style="border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit&#160;No.</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1.06%; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:90.56%; border-bottom:solid 1pt #000000;">
<p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:90.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:90.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="trvi-ex991_6.htm"><span style="text-decoration:underline;">Press release issued by the Company on November 10, 2021*</span></a></p></td>
</tr>
<tr style="height:4.95pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:90.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:90.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The exhibit shall be deemed to be furnished, and not filed. </p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TREVI THERAPEUTICS,&#160;INC.</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: November 10, 2021</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:10%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:42%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Lisa Delfini</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: Lisa Delfini</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title: Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>trvi-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
trvi-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gbpecyqoaeqe000001.jpg" title="" alt="" style="width:216px;height:129px;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Trevi Therapeutics Announces Third Quarter 2021 Financial Results and Business Update </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Phase 2b/3 PRISM (Chronic Pruritus in PN) Trial Approximately 90% Enrolled, </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Top-Line Data Readout Expected First Half of 2022 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Phase 2 CANAL (Chronic Cough in IPF) Actively Enrolling, </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Top-Line Data Readout Expected First Half of 2022 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Management to Host Conference Call at 4:30 pm ET </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">New Haven, Conn., November 10, 2021<font style="font-weight:normal;"> &#8211; Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of an investigational therapy Haduvio&#8482; (nalbuphine ER) to treat serious neurologically mediated conditions, today announced financial results for the quarter ended September 30, 2021, as well as provided business updates.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;We continue to execute on enrollment for both of our trials, with PRISM, our Phase 2b/3 in chronic pruritus in prurigo nodularis (PN) now being 90% enrolled. Haduvio is the most advanced oral compound in clinical development for both pruritus in PN and chronic cough in patients with idiopathic pulmonary fibrosis (IPF),&#8221; said&#160;Jennifer L. Good, President and CEO of&#160;Trevi Therapeutics. &#8220;With large commercial market opportunities in our first two indications, we are excited to conclude these trials and report topline data in the first half of 2022. The potential for indication expansion in both pruritus and chronic cough is significant, and we continue to focus on completing these trials while preparing for further clinical development, future regulatory filings, and the commercial launch of Haduvio. There continues to be a high unmet need in these two patient populations.&#8221; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Key Business Updates</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:11pt;color:#000000;">Phase 2b/3 PRISM trial of Haduvio for severe pruritus in patients with PN</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Approximately 90% of the planned 360 subjects have enrolled </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Approximately 90% of eligible subjects continued into the open label extension study</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Top-line data readout expected in the first half of 2022</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:11pt;color:#000000;">Phase 2 CANAL trial of Haduvio for chronic cough in patients with IPF</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Enrollment steadily progressing with top-line data readout expected in the first half of 2022</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Upcoming Meetings</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company plans to present at the following upcoming conferences: </p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Stifel 2021 Virtual Healthcare Conference, November 15-17, 2021</font></p></td></tr></table></div>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">5<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases, November 16-18, 2021</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">11<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Annual LifeSci Partners Corporate Access Event, January 5-7, 2022</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">H.C. Wainwright BioConnect Virtual Conference, January 10-13, 2022</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Third Quarter 2021 Financial Highlights</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Cash position: <font style="font-weight:normal;">As of September&#160;30, 2021, the Company had total cash and cash equivalents of $29.3 million. In addition, subsequent to the end of the quarter, the Company raised $14.8M through the sale of common stock and warrants to fund Company operations and the development of Haduvio in both of our clinical trials.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Research and development (R&amp;D) expenses: <font style="font-weight:normal;">R&amp;D expenses for the third quarter of 2021 were $4.7 million compared to $4.8 million in the same period in 2020. The decrease was </font><font style="color:#000000;font-weight:normal;">primarily due to decreased purchases of clinical trial supplies. This decrease was partially offset by an increase in personnel-related expenses due to increased employee headcount. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">General and administrative (G&amp;A) expenses: <font style="font-weight:normal;">G&amp;A expenses for the third quarter of 2021 were $2.2 million compared to $2.4 million in the same period in 2020. The decrease was primarily due to decreased market research costs as well as lower stock-based compensation expense which were partially offset by higher legal and other professional fees.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Net loss: <font style="font-weight:normal;">For the third quarter of 2021, the Company reported a net loss of $7.3 million, compared to a net loss of $7.4 million in the same period in 2020. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Conference Call</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To participate in the live conference call today, November 10<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> at 4:30 p.m. ET, please dial (888) 317-6003 (domestic) or (412) 317-6061 (international) and provide access code 6938277. A live audio webcast will be accessible from the &#8216;Investors &amp; News&#8217; section on the Company&#8217;s website at <font style="text-decoration:underline;">www.trevitherapeutics.com</font>. An archived replay of the webcast will also be available for 30 days on the Company&#8217;s website following the event. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">About&#160;Trevi Therapeutics, Inc.<font style="font-weight:normal;"><br />Trevi Therapeutics, Inc.&#160;is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio to treat serious neurologically mediated conditions.&#160;Trevi&#160;is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with PN and a Phase 2 trial for chronic cough in patients with IPF. Trevi is also developing Haduvio for the treatment of levodopa-induced dyskinesia (LID) in patients with Parkinson&#8217;s disease. These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Founded in 2011,&#160;Trevi Therapeutics&#160;is headquartered in&#160;New Haven, CT.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">About Haduvio<font style="font-weight:normal;"><br />Haduvio, an investigational therapy, is an oral extended-release (ER) formulation of nalbuphine. Nalbuphine is a mixed &#312;-opioid receptor agonist and &#181;-opioid receptor antagonist that has been approved and marketed as an injectable for pain indications for more than 20 years in&#160;the United States&#160;and&#160;Europe. The &#312;- and &#181;-opioid receptors are known to be critical mediators of itch, cough and </font></p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;">certain movement disorders. Nalbuphine&#8217;s mechanism of action may also mitigate the risk of abuse associated with &#181;-opioid agonists because it antagonizes, or blocks, &#181;-opioid receptors. </font><font style="font-weight:normal;">Parenteral n</font><font style="font-weight:normal;">albuphine is not currently classified as a controlled substance by the DEA in&#160;the United States&#160;and by regulatory authorities in most of&#160;Europe.&#160;Trevi&#160;intends to propose Haduvio as the trade name for nalbuphine ER. Haduvio is an investigational therapy that has been granted Fast Track designation by </font><font style="font-weight:normal;">the </font><font style="font-weight:normal;">FDA for the proposed indication of reduction of moderate to severe pruritus in patients with prurigo nodularis. Its safety and efficacy have not been evaluated by any regulatory authority. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-weight:bold;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Forward-Looking Statements</font><font style="font-weight:normal;color:#000000;"><br />Statements contained in this press release regarding matters that are not historical facts are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties and actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the impact of the COVID-19 pandemic on Trevi&#8217;s clinical trials, business and operations; the expected timing of enrollment and for reporting top-line data from Trevi&#8217;s Phase 2b/3 PRISM trial of Haduvio in patients with PN and Phase 2 CANAL trial of Haduvio for chronic cough in patients with IPF; Trevi&#8217;s business plans and objectives, including future plans or expectations for Trevi&#8217;s product candidates; expectations regarding Trevi&#8217;s uses and sufficiency of capital; and other statements containing the words &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; and similar expressions. Risks that contribute to the uncertain nature of the forward-looking statements include: uncertainties regarding the success, cost and timing of Trevi&#8217;s product candidate development activities and ongoing and planned clinical trials; uncertainties regarding the scope, timing and severity of the COVID-19 pandemic, the impact of the COVID-19 pandemic on Trevi&#8217;s clinical operations and actions taken in response to the pandemic; uncertainties regarding Trevi&#8217;s ability to execute on its strategy; the risk that positive results from a clinical trial may not necessarily be predictive of the results of future or ongoing clinical trials; potential regulatory developments in&#160;the United States&#160;and foreign countries; uncertainties regarding fast track designation and the effect such status could have on the regulatory review or approval process;&nbsp;&nbsp;</font><font style="Background-color:#FFFFFF;font-weight:normal;">uncertainties inherent in estimating Trevi&#8217;s cash runway</font><font style="font-weight:normal;color:#000000;">, future expenses and other financial results; including Trevi&#8217;s ability to continue as a going concern </font><font style="Background-color:#FFFFFF;font-weight:normal;">and its obligations under its loan facility;</font><font style="font-weight:normal;color:#000000;"> as well as other risks and uncertainties set forth in the quarterly report on Form 10-Q for the quarter ended&#160;September 30, 2021&#160;filed with the&#160;Securities and Exchange Commission&#160;and in subsequent filings with the&#160;Securities and Exchange Commission.&#160; All forward-looking statements contained in this press release speak only as of the date on which they were made.&#160;Trevi&#160;undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Trevi Therapeutics, Inc. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Selected Balance Sheet Data</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">(unaudited)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">(amounts in thousands) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">September&#160;30,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,318</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,001</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Working capital</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,794</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,714</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,596</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,131</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,328</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,954</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders' equity</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,380</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,282</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Trevi Therapeutics, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Selected Statement of Operations Data </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">(unaudited)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">(amounts in thousands, except per share amounts)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.8%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">September&#160;30,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Nine Months Ended</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">September&#160;30,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.8%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,718</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,828</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,805</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,768</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,229</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,416</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,398</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,528</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,947</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,244</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,203</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,296</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,947</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,244</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,203</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,296</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (expense) income, net</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(306</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(145</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,232</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,253</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,389</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,435</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,270</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (expense) benefit</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,255</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,378</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,420</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,235</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per common share outstanding</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.34</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.41</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.25</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.30</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Investor Contact</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Katie McManus</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trevi Therapeutics, Inc.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">203-304-2499</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">k.mcmanus@trevitherapeutics.com</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Media Contact</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rosalia Scampoli</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">914-815-1465</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rscampoli@marketcompr.com</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gbpecyqoaeqe000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gbpecyqoaeqe000001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" $H >\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHIXQ+!(KJW*LIR#2'<=11D=<T9% !1110 4444 %%%% !1110 4444 %%%%
M!2%EZ9I:_/\ _P"#C3X]?&K]G;]B3P_XW^!'Q4U[PCK$_P 1+.TFU+P_J4EK
M,\#6EXS1ED()4LBDCIE1Z5TX/#2QF*A0B[.3M<Y,?C(8#!SQ$U=15[(_0#</
M6C</6OY3Q_P5/_X*1X_Y/C^)_P#X6%U_\71_P]/_ ."D?_1\?Q/_ /"PNO\
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M_CE>E_L=?\'%_P"T-^TI^U+X#^ GB/X >#=-L?%WB:VTRZOK&ZNVF@CD;!9
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MVT^3/SCCS.N)\BSSDP^(DJ51*459:=&M5T:OZ-'Z6I_P<R?M*-_S;CX']O\
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M_9_\&_\ @9=__%U(G_!P_P#M"2?\T!\&C_M[N_\ XNOSUA@)Y?\ _55B./\
MSZU]L^'<EV5%?>_\S\XCQ5Q'N\0_NC_D?H0G_!PU^T"QP?@%X._\#+K_ .+K
MUK]B7_@KO^T=^U]^T?H/P4A^"OA>QLKTRW&L:E;S73M:6D2%W?EL DA8USQO
MD7-?E)%'CDK7ZJ_\$!/V>FT#X?>*/VE=:T\K<:]=?V1H<K?\^D)W3L/9IMJ_
M6 UY&=99DN7Y;.K&DN;9:O=_/IO\CW^'<XX@S;-Z="5=\M[RT7PK5].NWS/T
M \:>(?\ A#_!VK>+3:FX&EZ;<7A@\S;YGEQL^W.#C.,9P<5^>*?\'"VC.N?^
M&6;K_P *U?\ Y&K[\^-7_)&_%O\ V+-__P"D[U_.G%&QZ"O$X7RO YC3JO$0
MORM6U:WOV:/IN,<ZS+*JM%86?+S*5]$]K=T^Y^F@_P"#A#16X'[+=U_X5B__
M "-4B_\ !P1HN.?V7[K_ ,*Q?_D:OS/CC"BI43=Q7T_^K.2]*7_DTO\ ,^._
MUOX@6];_ ,EC_D?I:O\ P<"Z*W3]E^Z_\*I?_D>ON+]G'XQ)^T!\#_#?QFBT
M%M+7Q#IXNET]KCSC!EB-N_:N[IUP*_GWAAK]T/\ @F^,?L-_#48_YEU?_1CU
M\YQ-E.7Y?A83P\+-RMNWI9]V?6<(YWFF:8V=/$SYDHW2LEK=+HD>W4445\6?
M?A1110 4444 %%%% !1110 4444 %%%% '\^O_!TC_RD6T'_ +)7IW_I=?U^
M;H!;J>*_2+_@Z1(/_!1?003_ ,TKT[C_ +?;^OS?7!^\?PK]@R/_ )%-'_"C
M\%XD_P"1YB/\3!5[D5*D9)S0D9/-2HG. *]8\"4@5.P-2*N.!0!V J1$ .36
MBB82D(B<\U?T7P]KOB*Z^P>'M&NKZ?'^JL[=I& ]2%!P*LZ=KFBZ1MDMO#%O
M>3#[TFIR-(F?41H4'X,7%7[SXM?$&[LCID/B::RL^GV33%6UBQZ;8@H_.A\_
M1 O9[R?W']5G['UI=6'[)GPQL+Z!HIH/A]HT<T;=486,((/N#7S#_P '",/@
M"7_@GXQ^)5Q<QZ8OC?2R?LH.]Y,387@$XZ^GUKZ;_8V=Y/V1/A;(\A9F^'>B
MEF8Y)_T&'FOF+_@X6\!Z_P#$C_@GRWAGPZ;=;AO'&ER;KF0JH4";)R ?7TK\
M=R^W]N0N[>_^I_0&;7_U:J\JO^[V^1^'ME\6_P!FWP>=GA3X.R7CK]V:_C1L
MGUW2M(1^0JQ=_MF:U!%]E\.> +&UB'W4FN6<+^"A*L^'_P!BG4)$63Q+XXAC
M;^.'3[4OQ_ON5_\ 0:Z.W_9Q_9^\+R*FO:U+<S?\\;[5E4M]$C"G^=?J3E@5
MO>7WL_#5',N72T%\D><ZC^UI\7[QB;2XTZS']VWL0W_HPM69-\??C9KDGE#Q
MM=EV_P"6=G;QQG_R&@KZ&T#X;_""QVRZ#\-X)B!\LTFELWY-.!G\#BNNL+6T
MM(%CL],CM4'2..-5Q^"\5/UC#Q^&G]]@^J8JI\59_*__  #Y.A/[17B/YX9/
M&5RC_P 2M=;#_P"RU:MO@M^T!KA^?P[JC;OXKR^"?^C'%?6*J7/4U?M?#7B*
M[T]]4M- OI+6-<R74=J[1J/4L!@#\:?UZ4=HI!_9<9?%.3_KYG=?\&[/P5^(
MG@+]O:_\0^*M)CMX6^'>HQ[_ +9'(Q8W-GQA2?\ (^E?M%\6OBAX2^#'PWU?
MXH>.=1%MI>BV;7%U)_$W0+&H[N[%44=V8#O7Y>_\$5/%OAC4OVT;[1=/\0V-
MQ>1^![\O:PW2-(H%Q:9) .>*Z#_@N'^WE\/=+^(NG_LH#QW%;KH4<>I>)K5(
MY&+74J9MXFVJ1A(F\S'<RJ>JBOB,VPM;-N(%3M]E-V71?U8_2LAQ^&R'A&5:
M_P!J25WO)VM]V[\DSX2_;CO_ -I;]O'X]ZA\:OB=XMTFWMV8P>'M!CNIGATB
MQ#$I G[L M_$[X!=R3P, >1+^QIXX4\^*])Y_P"NO_Q->F_\-,?!I.GBEG_W
M+&;_ .(IJ_M._"$G)U:\_P#!=)_A7W%#ZUAZ4:=.%HI62L?E^*^HXJO*M6J<
MTI.[;ENSSA?V-_''3_A*M(_\B_\ Q-(W['/Q &5B\1:,W_;249_\AFO2U_:<
M^$+D#^VKI5_O'3Y<?RKI/AI\2O#?Q@\76?P_^%MMJFO:UJ$FRSTO2]%N9II#
MZA5C)P.Y/ ')(%:2Q.-A%MK1>1S1P>65)*,'=O9)ZL\*F_9%^)UO_J+K2)O]
MRZ<9_P"^D%,7]G#XYV'_ !Y6:\=/L^K(O\V%?IQX0_X)$_MB>*-.BU*_L/#>
MA^8N?LNL:TWG+QW6"*51^+9'I5?QY_P2B_;%\":7)JUKX8T;Q#'$,M#X=U8R
M3;?79,D18^R[C7GQXBPO-RNK!OU_X)ZTN"\=[/G]A42]'^5KGYH/\._VG- '
M[E?$"A>UGK!<?DDAI(_%'[3OA[Y[A_$R*O\ %<V+RJ/Q="*^IM3TO4]$U:XT
M'6M-GL[ZUE,5U9W4+1RPN.JNAPRD>A -0M'<!2T 4D=F8C]<&O06.YE[T$SQ
MI97ROW:DE\_^&/F6V_:5^,NES!-1U2"1OXDN]-C3/_?*K7MG['__  56^,/[
M*GQ7LO'=EX8L;W2Y62'Q#I-O/)$NH6N?F7DL!(O+(^/E;_99@>DNC=O"RZAX
M96Z7O'!+')N_[^;!7.ZMX9^$%YF3Q1\.%M?[TLFB.N/^VD*D#_OJBI+!8FFZ
M=6BFGNE_P+%4*>:8&M&K0Q#4HNZ;7^=_F?OO\(?BQ\/_ -H3X3Z+\6OAUJL>
MI^'O$FFI=6,Q7[T;CE'4_==3E'0\JP93R#7X4?MV?LV?LU_L[?M3>+/@KJUE
M>Z"UO??:=*F@CF6-[.=1+$4R'0A0WEDX W1MZ5]N?\$.OVA/AWX8O-6_94T'
MQ7:R65\TFK>&[/\ M/S?*G 'VF!%9BPW*/-VC@%)3U)J;_@O?^Q/_P +=TSP
MK^TKX6N8;74M)5M$UN26-F6:V=C);%B/NA)#,N<')G4=J^'RG_A&SZ>%G)J$
M]GMYQ;_%>I^J9\O]9N%*>.A",JE/XENNTTNW22\D?F"_[//A76/F^'OQ<TJ]
M8_=M[J10_P":$G_QT5A^(/@A\3?"P+ZCX4GFB'_+:R_?KCU.S) ^H%:&K_LV
M?%/1@7BT:"_5>=UA<!OT?:WY"LVUU3XF^ ;CR!J.L:2R](9&DC7_ +Y;@_E7
MZ#&<Y?!44O7_ ('^1^4RI4J?QTG'TV_'_,Y^.$E]K _+QMK]1?\ @W._: %E
MJ_CC]F'5[\[;J./Q#H<#?=5TVP78'N0;8@>B,?7'YW3?%;6-;"P^,= TG6AC
M'G75GY<X'M)$5(_6O5/V$?CMX-_9V_:X\$_%ZS?4M)M;;64M=6MY)%N(FL[@
M>3-EQL8!4<N 5;E!DBN#.L++'994HN.MKJVNJU7GKMMU/:X<Q4<LSJCB%+2]
MG?3W7H_+2]]^A_0H**1"&165LC'!]:4G S7XN?T4?'O_  6Z^.P^$7[$^I>#
M]/O?+U3QW?1:+;HI^8VYS+<GZ>6GEG_KJ*_$F&+!_P \5]U?\%Z?CL?B)^U1
MIOP;TV[9K'P'HJK=1_PB^NPLTA_[\_9A]0U?#J1].*_6N%\)]4RF+:UG[S^>
MWX)'X7QEC?KV?3L[QI^XOEO_ .3-_<$<9(S5B./'-$<1!R>M6(XLGYA7T!\O
M:Y<\+>&-:\7^(]/\)^';&2ZU#5+Z*TL;:-<M--(X1%'U8@?C7]#W[.?P8T7]
MGOX'>%_@SH+(\/AW1X;62XC3;]HF S+,1ZO(7<^[5^3G_!%+]GH?%W]K6/XA
MZQ8^;I?@*Q_M%V/W?MKDI;*??/F2#WAK]F5&T8S7YUQECO:8B&%B](J[]7M]
MR_,_6N ,M]CA:F,DM9OE7HM_O?Y',_&K_DCGBW_L6;__ -)WK^=R- %]*_HC
M^-'_ "1WQ9_V+-__ .D[U_/#&A;M73P7_!K>L?U.7Q _C8?TE^:!(]^#VJ:*
M+=@D4Z*'U6K447K7VY^>Q5M1L4)SDC_ZU?N1_P $Y./V'_AN/^I=7_T8]?B!
M'%GKP*_<'_@G2"/V(_AP,?\ ,O+_ .AO7Q_&7^XT_P#%^C/NN _^1E5_P?JC
MVJBBBOSH_5 HHHH **** "BBB@ HHHH **** "BBB@#DO&OP$^!OQ*UA?$/Q
M'^#7A3Q!?I L"7VM^';:ZF6,$D('E1F"@LQ S@%CZFOSB_X.0OV;OA;X2_8A
M\.WOP9^ GA_3-4F^)5E"\WAGPM!#.\9L[TE"T$8;;D D'CCVK]2J_.K_ (.9
M_%WB7PA^P/H<_AK5)+.6Z^)%E%)/"V'V&SO20#VSCJ.:]C(ZE;^U*,4_M+2^
MAX/$E&A_8N(E**^%ZV5S\)9O@MK/AZW6Y^(FO:;X>5E#+;WEQYMTX/I!%N?_
M +ZV^^*S+E_A_IK>7I=KJ&JR+_RVO&6VA;_MFA9R/^!J:QY9)[J5I[F9I)';
M,DDC$LQ]2>]=G\.O@/\ $/XC[;O2-*^RV+?\Q"^S'&?]W@L__ 01ZD5^N6Y8
M\U27Z'X+?VDN6E']7_E^!RD]S]H'EQ6<$*!LJD,?3_@3$L?Q)KU[_@G_ .#Y
M?&7[:OPGTJ?PO_:VGM\2-%75+>2Q\^!H#?1!Q*I!785R"&X(ZUW7A']EGX8>
M"K3^U_&E[_:DD*[I9KV00VR>^T'_ -"8CVKT[]DS]H7X6Z5^U_\ "GP)X'M/
MMAN/B-HMNGV"$16L.Z^B!.<#=C/\((/K7'B<5S8>:I1;T>OR.[!X/EQ=.5>2
M7O+3YH_>H?LD?LJ8Y_9E^'W_ (1EC_\ &J:W[(W[*IZ?LS?#W_PC+'_XU7H@
MSCFBOQSV]?\ F?WL_H3ZMA_Y%]R(-,TS3]%TZ#2-)L8;6UM85BM;:WB"1PQJ
M %15'"J   !P *^0O^"Y&F^)M5_8@:T\*>(8]+N3XPTTM>26:S;4_>Y 5N,]
M.M?8E?#'_!PSXZU_X>_\$]9M>\-31QW3>--,A626,/L#";) /&>.^:[<IC*6
M:44M^9?F>;G\HT\EQ$I;*#V]#\H$^%.DQQM?>./&FM:P%^:8W^J-#;C_ +91
M%$Q['-9M[\9O@%\-5:TT:^T_S /FAT.S5]WU= $S]6S7@\>B_&SXR7 O'M=8
MU@$_+--E8%^A;"+^%=1I?[*'B.PA&J>//&FD:' O.YIO,93^.U?R8U^L_5Z<
M?XM3Y+^OT/P/ZY6GK0I?-_Y_\$ZO4?VN;W4%8^"OAQ/-&IQ]JU"?:B^[;1@?
MBXKG-4_:"^*M_*RW7CK0=%C9>$L8!<L!]567!^K TL^A?LN^&@K>(/&^L>))
MT^]'9Y\L_3 48^CUL_"[X@_!?5?BAX<\%>%_@79F'5=>L[)KK5)@SA99T0G!
M5R.&[-6JIT8Q<HTV_5?Y_P"1SRK8B<E&=5)OHG_\BOU/U=_X)#_\$FO"T/PM
MT7]JC]K6^OO&6N>)+./4/#OAG72W]GZ99R+NAEEM2Q2::1")/W@*HK*-@<$U
M^D=AI]EI=I'8:=9QV\$2A8X88PJ(H[ #@#Z4:=9VNGV45A8VZQ0P1K'#&BX5
M%48  [  5-7XYC\=B,PQ#JU'Z+HEV2/Z*RO*\+E.$C0HQV6KZR?5M[N_X;(X
MJZ^"_P #O"_Q N/VA%^&N@V/BBVTFXM[KQ1;Z='#=O:-MDD2250#(N8E;YLX
M*\8YK^>/XZZC^TY\;_C;XJ^-.MZ7X9TZ?Q-KUSJ&+FQLGDBCDD+1QEVC=B$3
M:H)).%%?O#_P4EU?4-)_85^*"Z1JBV5YJ'A*YTVUNF)'EO= 6X88YR/-X]Z_
MGY@_8W<X?5OB4W^UMT_^K25]CP?&/LZE>I+72*NF]%KI]Z/SGQ$J5/;4<-2@
M[:S=FHW;T3>FKT?WC!X)^.P7;=?%3PS9\ ;5FBCQ[?)#3AX1^,;#RY?V@_#J
MG/S#^U!G_P!%BK4?[+7PGL>-:^)4RXX_X^K>+G_@0-*WP"_9WA7,_P 3'Q_V
M&+;_ .(K[3VE/H__ "4_,94:W56]9L@7P?\ &B>3R;;X]>'YF/&U=2!)]L>6
M<U^[?_!,7]ARU_8\^ .FKXT%MJ/Q"URU6Y\6:W]E19(W<!A91D#(ABX7' =P
MSD#< /Q5^"?PB_92\,_&/PGXM\6_$%IM'TOQ+8W>J0'5+>02V\5PCR(5"@G*
M*1@$$YZCK7[+VO\ P66_85NCMM/'FI3>GE:66_DU?)\5?7:].%##P;B[N5HV
M[66GW_<??<!?V7@Z]3%8RI&,U91O.^^[2?797]>Y]5B@\C%?,*?\%=_V-I>8
M]<\0-[KH,G^-._X>X?L>$9&M:_\ CH,G^-?$?V7F7_/J7W,_4O[>R7_H(A_X
M$CR?_@MS^P!X#^-GP1U3]J7PCX5NH_'/@FQ^U7UQH4@AN-6TQ!^]CD^5O,:)
M,RH2-P5&0'# #\8]-^(M[I4_EZ/\6/%&GLO_ "PU:'[1&GMQ(?\ T"OW.\??
M\%A/V.I_#>HZ)?Z;XUFCO+&:!FM_"C3J0Z%3D(YXP>]?B8?VAO'%O<MIOBWP
MGI-_%&VWR]0TUHY&7WYP#C_9K]%X4_M"&#E1Q$':+7+?L^BNGHFOQ/QKC[^Q
MZF94\3@ZJYII\W+KJK6;LTTVG\[%[0OCM\4;>1GC\2^'==C7KY^+5S] _E9/
MT!KK-+_:BCLV2/QG\/\ 4+'<<>?;MN1O<!PN1]":XZV^(GP,\0GR_$_P:^PY
MZS:3<<Y^@,?]:U-/\(_ 76DV^#_BGJ&AS2?\L=2'R_0Y"@_]]'\:^@J0HOXZ
M;7HO\O\ (^5PTL0M854_5[_^!*_XGNW[-O[2GPD\'?'#PM\7-*UK3X=0T+68
M;@R7UN(9O*)VS(K.!G=$SH=IY#5^TW[0_P )K+]HC]G_ ,2?"R+6#:?\)#HL
MD>GZE" WV:<C?!..?FVR!&QGD#'>OYXM:_9I\;R6YO?#FHZ7K%O_  R6DBQM
M(/I]W\F-?T#_ +$WB35/%W[(/PUUS789([Z3P3IR7RR8W":.W2-\X]64FOA>
M*Z-.BZ.)HRU3MYJVJ_4_5> \16Q$<1@\1"R:3\G?1_A;J?B+KNE_M/\ PTU:
M\TK5;;3M>>QGD@N[>2W\FXA>-BK*5&WY@01@;NE4;3]H_0I96T#X@^!KRPDZ
M3Q21"51_O(X5@/P-?47_  5S27]F?]KV34;SPMO\.^.;(:M975FV&CN =ETA
M5N';S,2\%<"8#'%>&V&L?"[XOZ=]C1K/4OERUM<)MFB]\'##ZCCWKZ+"UXXC
M"PKRAI))W6GY::/0^4Q6$G@\=4PT*OO0;5I:W[>>JL^IS<7@S]G?XF#=H,]G
M;W4@PJV,OV:0'_KDP /_ 'S6#XD_95UJSW3>%/$$-TJ\K;WBF*3Z;AE3^.VK
M_C3]ER AK_P#J6UAR+&^;(/^[)V]@V?]ZN.LO&OQ=^%NH?V-=:A=6YC_ .7/
M4%\R,KZKG/'NI_&N^ES25Z52_DSS:WLXNU>E;SC_ %^9^\W_  3X^*NN?&+]
MD/P3XH\6VS0ZW::2NF:U'),)'-U:GR&D)!()D"++])!7K'BWQ+I/@SPKJ7B_
M7[E8;'2K":\O)FZ)%&A=V_!0:_.O_@A9^UP_CGQ!XK^ /B.QAM;J2U36]-,4
MQVS,I6&<!3R#M,)QD\!C7TM_P5,\9?V-^R1KG@6RU:2SO/&4B:/#-"PW1Q-^
M\F;'=3&C1G_KJ/45^7X[+94\[>&:LI27R3U_!?D?M66YM"KPZL6GS.,6G?=R
MBK:^;=OO/Q1^+_Q%/QU^,/B;XL^(M1N+:\\2:Y<Z@PN$,J1+)(62/<OS (NU
M!A3@**R[;P'K]Y"UUH4,6J1XRW]FS"5U'J8A^\7\5%=!XL^ /CGPL&N;*V75
M+5>?.LU/F >\?7\MWUKD[7S[699;>1HY8S\LB,59#]>QK]9ING[-*D]%H?AU
M6-7VKE63NW=OU_ :+:2"9H)HF213AHW7#*?<=JFBBVCD5UFF?%'4)HDL?'.C
M6NOVJ\ WBXN$_P!V8#=^>:]/_9R_9J^'?[4/QC\.?#_X?^)+BSDU+4HQJ.EW
MV-Z6JG?.R-G^&)7(Y;G .,UG5Q$</!SJJR6K>Z.C#X.6(J1A1=Y-I)/1Z_@_
MO/TM_P"".?[/?_"DOV0=-\3ZM8>5K'CBX.M79>/#K;LH2V3/=?*42#T,S5]8
M56T?2M/T+2;71=*M%@M;.W2"VA0?+'&BA54>P  JS7XQC,3/&8J=>6\FW_DO
MDM#^@<!A*> P=/#PVBDO7N_F]3F?C1_R1[Q8/^I:O_\ TG>OYZ8X2>"O-?T,
M?&49^$'BH?\ 4MWW_I.]?SXP1J%SBOM>"_X5;UC^I\!Q]_&P_I+\T$46/ZU8
MCB]12Q19_AJ=(RW"CGO7VK9^>K42),-C'-?MW_P3M&W]B;X<C_J7E_\ 0WK\
M38H@G4<U^V?_  3QX_8I^'0_ZE]?_0WKY#C#_<:?^+]&?=<"?\C"I_@_5'L]
M%%%?G9^I!1110 4444 %%%% !1110 4444 %%%% !7YU_P#!S!X1\2^./V'/
M"V@>%=)EN[J3XH6/RQK\J#[%??,S=%7W) K]%*^-?^"XLT%K^R'I=U=3K'''
MXWM7DDD8!546EX223T %>ED\W3S2E)=&>/Q!3C4R6O%[.)^)WPH_98\*>#5C
MUGQCY.L:@OS[)%S;0GV4_?\ JPQW %+\3_VIO"/@XOHO@N*+6+Z/Y6D1O]%A
M/IN'W_HO'^T.E>:_'7]H35_'M_-X<\*7TMOH4>4/EY5[WG[S=]GHOXGG@>8A
M<<_I7ZU3PLJCYZ[OY'X16QU.BG3PZMY_U^9N^-_B7XV^(EW]I\6:]-,BMF*U
M5ML,7^Z@XS[]3W)KW3_@F-\$_$_B[]L+X5^.KE39Z7I_Q$T>:.:5.;IDOHCM
MC'<9&"W0<@9(('F_[._P3?XGZXVLZ[&RZ+I\@^T#D?:9.HB!],<L1VP."V1]
MP_LM76B^&_VD/AE',\5K;CQ[HMM;1JNU=S7L*HB@>^  *RS#$*G0E2IKH_EH
M:Y5AI5L53K57]I?/5?@?O0.E% HK\8/Z*"OB;_@OQXPT+P+^P-)XBU_PXFJ1
MQ^,M-6&TD1"#(?-VM\P(&,'G&1VK[9KX=_X.#/ NN_$;]@-?#&@"(32>.M+=
MI)GVK&H$V6/<]>@!->ED_*\TH\VW,CQ>(G-9'B'#?D=ON/PM\6_M3_$_Q"&M
MM'N(=&MMNT1V*9DV_P#71LD?50M8WASX9?%KXLW0U.#3K^\63[VI:E,WEGZ2
M2'YOHN3[5[W\./V9_ '@A([W5K4:QJ"\_:+R,>6K?[,?('U.XYZ$5UWC/QUX
M2^'>DC4_$^J1VT?2&-1NDE(_A11R?Y#N17ZY]:IT_=H0_K\S\ ^IU:D>?$U-
M/7^D>1^%OV,X4"R^-O%[%N]OID>!_P!]N/\ V6O6O@C\*O@3\,?B]X.N;G3=
M.AN9/%.G?9Y-6N!)([_:8P"BN>N?[H%>3ZC\:?C%\6KJ33?@_P"%YK*S5MKZ
M@RJ7'/4R-\D?'898>M1_!+P;X+T+]H7P7??$7XIMJNK'QEINZRT93<-YGVN+
M&^=R% ]0!GTJ*L<14IR]I.VCT6^W6VPZ-3"TJT'1IWU7O/1;]+[_ "/Z@5VX
M^44M-C^[3J_%#^F#X[_X+NWGB&#_ ()Q>*+'PQJRV-U?:SI,/VIM06U"*+V*
M0_O6=0N?+QUYSCN:_ J\\&75PS2>*/BSH8;JPDU66[/_ )"1\_G7]"?_  60
M\):+XQ_8<UC3_$&EQ7EK#KFFS20S [3BX50>/=A[5^2>F^!O!.B*%TOPGIMO
MC_GG91J?SQ7Z1PEB%1RN22^T_P EU_X!^*^(>#EBL\BV].2/?O+II^9\K6?@
M7PC<8$'Q(AN/^O+0[N3^:+6A#\+=&E&8M=UJ7C.8?"DY _\ 'J^KX88HA^[0
M+CIM&*FSC@O7U'U^71/[U_D?!_V33ZM?<_\ Y(^4$^$VFM\JZMKB^[^$KC'Z
M,:9+\*]*AYE\8/#_ -?GAV]3_P!!C:OK,=>6J5%P/F;\,]*?]H5.WY?Y$_V/
M1Z/\'_\ )'R39^"[NS<?\(_\4]$#CHJZI):,/^_J)BNDTF3]I+1@)M!\17VI
M*O*_8]6BU)?^^0\G\J^CKK2=+U!/*OM-MYU/\,T*N/U%8M]\#_A9JK>;=>";
M*.3_ )Z6JF!OKF,K3^OQE\<?P3_R%'*)Q_AR:]&U_F>1V'[1/Q@\*2>3XS\-
MQR?-S]OT^2VD^G&!_P".UUNF?M)?#7QA MAX^\'-#&>\]NEW"/S&[\E-=+-\
M$]0LX?+\&_$O6;%?^?2^=;RW(]-DG;\37*^(OA?XMT_?-XI^%&CZ_!WO?#LC
M6=S]2B\$^P0UFYX6KTL_)V_/3\3MIT,?16LFUYJZ^]7?X(V8?@O\!OB1 UWX
M,U)()&^9AI=X,I]8GSM'MA:YOQ'^R?XMTT--X6U>WU)>T,W[F3]25/YBL*W\
M'> M3O?^*-\=W6AZE&V$L?$,9A9']!.G Y]0#79:=\2?C3\)WCA^(.BOJFFG
MA;QF#;AZK,F0?HXR?:C_ &B'\.=_*6__  36*PM5?O*=O[T=EZVV^:/-VT[Q
MY\-]1Q.NJ:-<EN&5WAW_ $(P''TR*_H _P""6>L:GX@_X)__  QUG6;UKBZF
MT%_,FDQEL7$H'3V %?DKX4\:^ ?BWI;VUFT-TNW_ $C3KV(;T'NIR"/<9'O7
M[!?\$\M%TWP_^QAX!T?1[40VL&DR"&%6)" W$IP,Y/>ODN+L1[7 PC*-I*7Z
M,^_X!PBP^95)0G>+@_\ TJ)YQ_P5_P#V7/#7[1'[+\WB;4EDCO\ P/<'5+:[
M@95=+8C9<@E@1L"8E.?^>(Z=:_'7Q%^SEXT\.E=8\&Z@NI1K\\,EJWESJ/[P
M&>3_ +IR?2OZ+/$?A_1_%?A^^\+^(;%;JPU*SEM;ZVD^[+#(A1T/L5)%?SU_
M&7P]\2OV.OV@_%?P1BU:1XO#NMRV\,%TNZ*XMR=\,FW^'?$R-\I!YJ>#\76J
M49X=2^'5)]4]_P ?S-./L!0IXBGBW#2?NMK=-;>MU^13\#_M!>*_#%R-"\?V
M$UY'"P2222,I=0_4-C?_ ,"PWO7K:0^ _BSX;!*VNI6;_=_OPMC_ +ZC;\C^
M%<?HOC7X6_&ZWCT3QCI$=IJFW;#YCX.?^F4HQ_WR?R:L?5_A7\0/@_J3>*OA
M_J$EY:+S,H7YPG]V1.CK[CD=<+UKZ>I&G4G:W)+\&?'T95*4+W]I#\5ZH]%_
M9>35OV._VL_!?QOT^_>;P[::PEOK=PRY>UL;C,,[2!?O*J2,X8#&4&0._K?_
M  7,_:'U'Q5^U/HOPN\):])%;^!]%!EDL[HK_IEWMED!VGG$2V_7U;U.?*OA
ME\1='^)>CO)%$(;J)=M[9LV[;D?>&?O(?_K'WX_]ISP3XBUSQ->?%ZXU":^D
MU"97UAYCEDDP%#C_ &" !['V/'''#PJ9I"O67O1BX^M]OP<OO/2EB:E+):F&
MP[]R<E+T2W_%1]+,J^!/VCM0MGCT_P <V7VB/I]OM5"R#W9>A_#!]C7<ZSX!
M^&OQ?TW^V]/>$S./EU&QP) WI(.Y]0PR/:OGN.,#I6QX4\2Z_P"#M1&J^'M1
M>WEZ,HY609^ZPZ$?Y&*]*IA8WYJ;Y7^!Y='%RY>2JN:/X_U_5S2\<_"?Q/X
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MHE+]#!2/(VJ*L11A12H@4<5/# 2>17VQ^?V[!% 7.:_:S_@GJ,?L7?#P#_H
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MY<._E8_[L2^D4:XSC!<\G!;CYUGN/$/CCQ(+B]N);[4=1N%4-(<L[L< >PZ
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M&LD+AD8!E93D,#T(]17RW^U-H%SI/Q?NK^0?N]2M8;B-OH@C(_./]17G9?\
MQ_E_D>IFSE]5^:/;/@I_P6X_X*1? GX?Z?\ ##PC\<X[[2=+@6#35U_0[:^F
MMX5&%C$TB&1E48 #,V  !@#%=</^#A7_ (*@%<?\+6\/_P#A&V7_ ,17Q&BX
M& *?M^7&*ZY9/E4Y.4J$&W_=7^1Y\>(L\I14(8JHDM$N9Z?B?U@_LX^,M>^(
MO[/?@7X@>*;A)M3USP?INH:C-'$$5YYK6.21@HX4%F)P.!7@_P#P60&?V.6_
M[&JP_P#:E>S?L>#;^R5\+Q_U3W1?_2&&O&?^"QY_XPZ;_L:K#_VI7Y#@4HYQ
M!+^?]3^@LSE*7#M23W=/]#\"?VK=<NM3^*KZ/(W[G3+**.)>V742,?J=P'X"
ML?X +:M\8M!%WC;]J;;NZ;_+;;^.[&/>NB_:Q\,7>F?$6/Q(8V\C5+1"'QQY
MD8",OUV[#^->;Z5?7ND:E;ZIILS1SVLRRPR+_"RG(/YU^TT(J6$275'\T8JI
M*GF#E+I*_P MU^!]O*O\*5P?Q$EO8OCQ\);52WV5_&MH\F/NF075MC/O@MCZ
MFMSX5_$K1OB;X:CUG3V6.XC 2^M,_-#)CG_@)ZJ>X]P0.L\/^!M-\=_$'PGI
M]^?+DM_%VFW-K.%R8Y%N8^?<$9!'H?4"O$3]C4?/T3_(^EE_M5->S>[37WIG
M[[44BYQS2U^.G]( >1BOR5_X*?? FX^$'[4NJ>(+.U9=*\9,VL6,A''G.W^D
MI]1*2_L)5K]:J\&_X*(?LL:O^U+^SUJ'A_P(]I#XRT<F_P#"=Q>KF*2X4?-;
M2'@B.5,ID$;6V.<A,'V,DQT<%CDY/W9:/ROU^3_"Y\[Q1E<LTRJ4::O.'O17
M5VW7S6WG8_(I%"]#]:<B$\"O(Y?VF-;\):_>>#OB=\+[S3=6TNZDM=3M5EVR
M03(Q5T:*0 J0P((+'%;5E^U3\,)% FLM8C;T^QHV/RDK]0EA<1'7EOZ:GX33
MQF%G]JWK=/\ $],CB"#&*T-!U36O#>KV_B#PYJ]U87]I)YEK>64[130/_>1U
M(*GW!KR__AJ+X81C,=MJ\A_V;-!_.05G:E^UII<:E="\&7$A[/>72QX_!0V?
MS%8_5<1+3E^\[H8S"T[/G7R_X!]^?#3_ (*M?M-^";*/3/%4>C^*(HU"K-J=
MJT5Q@#',D)4,?=E)/<U@_$__ (.(_'OAG6_^$?\ !GP#\.W[PIB\NI=;G:,2
M_P!Q0J#.._/7CJ#7YT>+/CE\1?&L36=SJ:V5JZX:VT]3&''H6)+$?CCVKF8(
M&+K%&A9FX55&?P%8T^&<ME/GK4UZ*Z7X-'94XRSJ--4\/6DEW=F_Q39]P^-_
M^"\?[<_Q*U6UT?P>OAKPG!<7<<;+HND>=.ZLP4IYERT@!/JJJ1G@]*ROBC\0
M-6O+35OB'\0?$-UJEUY#/<7>IW32RSMC"H6<DG)(4#MG KP/X;^%O#OPQN(O
M'7Q2O5M[F-=^FZ*J[[@MVD=/X<=@V.>21@ U_&?C_P 9?&_7X?#NBZ9(MOYF
M;33XCDD_\])#TX]> H_$G:.6X.G42P]-1BMVEO\ /J9RS;,*U)O%U93D]HMW
MMYVV5_0M> I+B?X$^(A)<R1_V3?VUSILT;E6@FW+RC#E3P.G3=7ZU?\ !,__
M (*'W7Q.\"^&_A/^T%K&WQ)+IMO'I6OW4G_(4.P ),QZ3GLQ_P!83@_/]_\
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MKYTU/2QI>L7>E_\ /M=21?\ ?+$?TKZ41 !TKY_\7A)?&.K2QCY?[2GQCO\
MO#7TV!;YI(^1S**Y8F7#!CFOV0_8(&/V// (Q_S E_\ 0VK\>8H=W.*_8C]@
MWC]D'P$,?\P-?_0VKQ>+G_L5/_%^C/H."(VQ]1_W?U1ZY1117Y^?I@4444 %
M%%% !1110 4444 %%%% !1110 4$9&*** /@G_@M#_P2*M?V[O"L?QI^"L%O
M9_%+P]8^3#'(RQQ>(+1<L+61S@)*I)\J0G'S%&PI#)^!/C/P1XQ^&_BN_P#
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M6WU31?!^FV&HVZR*XCGAM8XY%#*2&PRD9!(/:O ?^"SG[+7QH_;!_8U;X/?
M;PU#JVO'Q587WV6?4(K9?)B$N]M\K*O&X<9R:_)\OJ48YW3G-KEY[MO:U^Y^
M_9Q1Q,N%ZM.E%N?L[)):WMLEW/Q6L?B=\(?V@/#_ /PB?C+&F7C-NCCN9@NR
M3'WH9<;2>V#@GI@BO,OB7\ /&?PZ=[Z"W;4M+'*WULG*+_TT3DK]>5]^U?2
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MO_(^?8H<#(K]@/V$@5_9$\!@_P#0#7_T-J^!X_\ @F)^V*OS'X<VG_@\M?\
MXY7Z(_LJ>!/$WPR_9Y\*^ ?&5BMMJFEZ8(;R!95D"/N8XW*2#U[&O%XFQF%Q
M&$A&E-2?-T:?1GT/"6!QF%QDY5J<HIQZIKJNYZ#1117Q)]\%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !117-_$'XP_"SX4?9?\
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M8M-?>M :<=&%%%%;""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"W2/]E7QQ;I]V/PW,%_!:\K_ ."3:@?LZ:HV?^9NN!_Y+VU>K?MC@M^RWXZ
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M97*R>Y4&OU-C<.@=6R#SD=Z^6/VX/V:-*L?V+M+T7PQ:JTWP\AMYH9%CR\L
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MF6*R^A.A@*G)[.,TXIS4??E"+U47]ST72RBO+W8J3NS\\?\ @GG^S/\ "O\
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M[7"A/V7O'2C^'PO=?^BS7:>#MO\ PB.EE!\O]FP8S_US%<7^UT,_LP^.^/\
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MW?L6****^\, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>trvi-20211110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-11-09T17:50:39.7264932+00:00 -->
<!-- Version            : 5.0.1.702 -->
<!-- Package ID         : 818557e885c3469b91c33895db5b4c14 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:trvi="http://www.trevitherapeutics.com/20211110" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.trevitherapeutics.com/20211110" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" namespace="http://xbrl.sec.gov/country/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" namespace="http://xbrl.sec.gov/currency/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" namespace="http://xbrl.sec.gov/exch/2021" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" namespace="http://xbrl.sec.gov/sic/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd" namespace="http://fasb.org/srt-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" namespace="http://fasb.org/srt-types/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" namespace="http://xbrl.sec.gov/stpr/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" namespace="http://fasb.org/us-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" namespace="http://fasb.org/us-types/2021-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.trevitherapeutics.com/20211110/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="trvi-20211110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="trvi-20211110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>trvi-20211110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-11-09T17:50:39.7264932+00:00 -->
<!-- Version            : 5.0.1.702 -->
<!-- Package ID         : 818557e885c3469b91c33895db5b4c14 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>trvi-20211110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-11-09T17:50:39.7264932+00:00 -->
<!-- Version            : 5.0.1.702 -->
<!-- Package ID         : 818557e885c3469b91c33895db5b4c14 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.trevitherapeutics.com/20211110/role/TemplateLink" xlink:href="trvi-20211110.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="trvi-20211110.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>trvi-8k_20211110_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="trvi-20211110.xsd" xlink:type="simple"/>
    <context id="C_0001563880_20211110_20211110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001563880</identifier>
        </entity>
        <period>
            <startDate>2021-11-10</startDate>
            <endDate>2021-11-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001563880_20211110_20211110" id="F_000000">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001563880_20211110_20211110" id="F_000001">0001563880</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001563880_20211110_20211110" id="F_000002">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001563880_20211110_20211110" id="F_000003">2021-11-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001563880_20211110_20211110" id="F_000004">Trevi Therapeutics,&#160;Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001563880_20211110_20211110" id="F_000005">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001563880_20211110_20211110" id="F_000006">001-38886</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001563880_20211110_20211110" id="F_000007">45-0834299</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001563880_20211110_20211110" id="F_000008">195 Church Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001563880_20211110_20211110" id="F_000009">14th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001563880_20211110_20211110" id="F_000010">New Haven</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001563880_20211110_20211110" id="F_000011">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001563880_20211110_20211110" id="F_000012">06510</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001563880_20211110_20211110" id="F_000013">(203)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001563880_20211110_20211110" id="F_000014">304-2499</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001563880_20211110_20211110" id="F_000015">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001563880_20211110_20211110" id="F_000016">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001563880_20211110_20211110" id="F_000017">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001563880_20211110_20211110" id="F_000018">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001563880_20211110_20211110" id="F_000019">Common stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001563880_20211110_20211110" id="F_000020">TRVI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001563880_20211110_20211110" id="F_000021">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001563880_20211110_20211110" id="F_000022">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_0001563880_20211110_20211110" id="F_000023">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139937265437640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 10, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001563880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 10,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Trevi Therapeutics,&#160;Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-0834299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">195 Church Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">14th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New Haven<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">304-2499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TRVI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M[126=W2L=G]1?&(N#H8D? DZ_M4UC%;O3OV[AE59<=)>* OG]N(RY@P6IWL
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M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ \H!J4Y>*NQS
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M"Q4&L&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ \H!J4P=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #R@&I3
MQPN-'NT    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " #R@&I3F5R<(Q &  "<)P  $P              @ '+
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( /* :E,&&!D:= 0
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M2P$"% ,4    " #R@&I3)!Z;HJT   #X 0  &@              @ 'G$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #R@&I399!Y
MDAD!  #/ P  $P              @ ',$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"   6%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="trvi-8k_20211110.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="trvi-8k_20211110.htm">trvi-8k_20211110.htm</File>
    <File>trvi-20211110.xsd</File>
    <File>trvi-20211110_lab.xml</File>
    <File>trvi-20211110_pre.xml</File>
    <File>trvi-ex991_6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "trvi-8k_20211110.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "trvi-8k_20211110.htm"
     ]
    },
    "labelLink": {
     "local": [
      "trvi-20211110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "trvi-20211110_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "trvi-20211110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "trvi",
   "nsuri": "http://www.trevitherapeutics.com/20211110",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "trvi-8k_20211110.htm",
      "contextRef": "C_0001563880_20211110_20211110",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "trvi-8k_20211110.htm",
      "contextRef": "C_0001563880_20211110_20211110",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.trevitherapeutics.com/20211110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-21-056180-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-21-056180-xbrl.zip
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M".E Q'?XE.>QB.;4S5 [<#4GM+3 2EPY"$=R,S'\)%S!_"OF5U)[!Z^^Y*_
M*U?T,4!C8I]N"\TCEXD6X.+JQY^X$8_DEZ9%3Z'PB\3._P=02P,$%     @
M\H!J4VJ4^_$B!0  ]"X  !4   !T<G9I+3(P,C$Q,3$P7W!R92YX;6SE6EV/
MXC84?:_4_^"F+[MJ\P7#SH"&75%F9H7*S""@[:HOJ^ 8L,:Q(SM\_?M>)X3
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M)2S&-CI./=62\?PQH" SA!4* 7P^SJ^=E&:;>*$KQ;P646$68C<<FGG4:>H
MLV1NP'L.*V(U($/%+D53F]#>"$3*CPP&GLJJ Z->KY=4Z83BI)C+-O42E"85
M9[K,,A@6]V@P83 >>!73^/(22T8U)G,.>-Z,H:I1^OW;3<<:L"$M/N=C/IHW
M@H%,CZ(5)>N$[$#@A,-7: ,J%15BN35I]WJC; ,^DOD-IG,J24'=H.^)H5I
MG'*UJ)M%\SC521&H)--10C6O]5.;<N5\0D !6E"2E%$;_Q\R297J*;(_0_YX
M5FAZ+E";+'8!Q@*QHJ>S@@0B+*G6I(3M))<.@Q\H*XNU'W\DPE"#.E!<2LI/
M2\E(J!%NOX)2<$&#2B;((^H<4ZLFNJGGV>/S4YL_DD".'796L'G@.W2,:\AP
MTO]RRD<-[(X)?(H>N6TS5SVJ9ZA[&RT,X?99X?H/7?T5B$N'V"7CC0M0N#8J
MW6N'/L0@CF2;]0%XK&Y4C\NUFCX!:?*C<-ZG3L!.2YEQ7AO;2(]]Y0)BQDT8
M7%"GY=IL]"L;+S>':6G>1-2[%%)P7H+U&8HH%L1S1=9M!(J_8$BBQ$,#B?JL
M$/"A[R"SJ7<#@3-2:SQ9X%%@)\546,+#E5I82"PAIQ85/^>GI2P\4SP\ SS"
M1>"%8HH*948T8ORK97L-_ZI=TI"I]8S?)2^YC:_['&A<38KE\G.S]6MV,9\W
M3D8JY0P5C^3#NGOVL^%!7@J)QN'YU"I,.IF69=L 1\QID91D)Y,>.'D7(S&-
M_A2N(\),F/>T!'R.__L)LP^I>.!NL>=)Z0T;NB]/XC?2\]4C]@W: -'3T/_S
MI ^C%?MTR)UQH\N'+""W[(FTO2%UH[* _Q]K&-BR</ZWGXQC_>2TY&>&['D"
M9I,,"68HMXFN?:GZDOP4B8T3G]IHW>=,:[F)JLE4H/#5:3\Q-'V!K4&Z.W%C
MG&[R1O4^40!*-D:U'JG@%(8D<<5Y4*L.J,,?W(8%4V0B/?]*+H!Y$,7S['F.
MG<9W;1$8WPK0]]M6]^J2=+H7W:L.61BPY99J$X!UKIK?VZUN"Z"ZN+TD5[\W
M?[FX_7I%FG??OK4ZG=;=[7J!-5<)[#\N.K^T;K]V[VZ/R*76U&!G6*W4%UC.
M/'XU5L6LQR\(CA=9Z'BK6>CZKOV-S#=6S+2QDC@G4J;@@C9*K?CK<^-DO[SK
MX"T0(^VKVRYI7]W?M;MK%I$KA>P^%$$(KXCT2(=9N/&)5L\H$T\0HWI@'Q*O
MOTL@RP%#4$/!)8=>KT;6@+H/#+V*"*E1+U<6!W?[:5?Y,P$NP7Q/2'*0/#,*
MUB4+)&&/Z"F-BIE]V'A!CI7SY-B],EJO(H-V*8%&HLWV60$VZ T;6@^A[<"F
MXS%,CKF%\UOOD0U[8/ ;^I'R=#X7?WOU%@]L+F0%OY6&YE-$978;WF8//,!^
MY2V4+*?ANN@2)MV43_@H0B:ZL-^P^.\IE/158OC@:D1!_B#&D#FG."0T(!V?
M6;AWM0EW27- T<]S^)%(_UU[C;>XDO8<1B(0SPH@3"SF.(%/+14VBI]C"-5S
M9BX-&DHO09#E.0[U ]9(?IR0)V[+ :PY3$8Y]J3:7DN;/"H, [8]?])E@D>'
M]:4")WFAXBV9-]T8X.3YYRE*HB'+]7C$OT+5\>-D/EG\XHN-$?I\45*=%27
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MB3^5]4K1K.1'G]:7Q+C2A;_U)*&^[W!+^5#62M*K%177\(N)./%+D/@QUGY
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MNNX &(\YS)+ >*ZG/.!AP%0M-DJ2@G%&7*7=1A]Z0+2KL9PQ#O[$86AD8A?
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MY>,%(Z:O)IRLXC#J]L;"8E*<W#^WZKBVIB^Z4#L7VMY4@+NN:]67D)X?X_[
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M#97G!8P-1._I2^2;.<ZQ,\ZFL8]].K&F"GC#:<Y19HU(F XPV*2!P9,<857
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M7\7)2WG7K-2'1WJ>VQQ]9?7O2J/N%VAS4>.]']R]1C'>ZRC_[MU?(,#II6$
MO_P_4$L! A0#%     @ \H!J4YQ3U<F[!   AA8  !$              ( !
M     '1R=FDM,C R,3$Q,3 N>'-D4$L! A0#%     @ \H!J4Z'G4O%4!P
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C:2UE>#DY,5\V+FAT;5!+!08     !0 % $4!   L0      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
